Table 3.
Association of clinical stage to different western blot bands in 155 patients of Meizhou who tested positive for HIV-1 antibodies between 2018 and 2019.
| WB bands |
Primary infection | Middle stage | AIDS stage | X2 | ||||
|---|---|---|---|---|---|---|---|---|
| Cases | Ratio (%) | Cases | Ratio (%) | Cases | Ratio (%) | p value | ||
| gp160 | 15 | 100 | 63 | 100 | 77 | 100 | / | / |
| gp120 | 15 | 100 | 63 | 100 | 77 | 100 | / | / |
| P66 | 15 | 100 | 60 | 95.2 | 69 | 89.6 | 2.93 | >0.05 |
| P55 | 4 | 26.7 | 12 | 19 | 12 | 15.6 | 1.11 | >0.05 |
| P51 | 12 | 80 | 50 | 79.4 | 58 | 75.3 | 0.39 | >0.05 |
| gp41 | 14 | 93.3 | 61 | 96.8 | 74 | 96.1 | 0.40 | >0.05 |
| P39 | 8 | 53.3 | 24 | 38.1 | 19 | 24.7 | 5.97 | >0.05 |
| P31 | 12 | 80 | 50 | 79.4 | 58 | 75.3 | 0.39 | >0.05 |
| P24 | 15 | 100 | 60 | 95.2 | 66 | 85.7 | 5.47 | >0.05 |
| P17 | 9 | 60 | 11 | 17.5 | 22 | 28.6 | 11.27 | <0.01* |
*, indicates a statistically significant difference.